When was Intabio founded?

Intabio was founded in 2015 and raised its 1st funding round 2 years after it was founded.

Where is Intabio located?

Intabio is headquartered in Sunnyvale, United States.

Who is the current CEO of Intabio?

Lena Wu of Intabio. They have also founded 1 company.

How many employees does Intabio have?

As of Jul 01, 2024, the latest employee count at Intabio is 16.

Is Intabio a funded company?

Intabio is a funded company, having raised a total of $30.7M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Sep 14, 2017.

When was the latest funding round of Intabio?

Intabio's latest funding was a $***** Series B round on Feb 06, 2020, with participation from 3 investors. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $899M in funding in 2026 to date.

Where does Intabio rank among its competitors?

Intabio ranks 10th amongst 67 active competitors, of which 23 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Microcaps, which secured $10.4M in Jun, 2024.

Who are the top competitors of Intabio?

Intabio's top competitors include Biological Dynamics, Fluidic Analytics and Miroculus. Among them, Microcaps secured the most recent funding round in June, 2024.

Intabio - 2026 Company Profile, Team, Funding & Competitors

Intabio is an acqui-hired company based in Sunnyvale (United States), founded in 2015 by Lena Wu. It operates as an Analytical solutions for life science, diagnostics, and applied markets. Intabio has raised $30.7M in funding from Northpond Ventures. The company has 67 active competitors, including 23 funded and 8 that have exited. Its top competitors include companies like Biological Dynamics, Fluidic Analytics and Miroculus.

Company Details

Analytical solutions for life science, diagnostics, and applied markets. The company provides mass spectrometry and capillary electrophoresis technologies, HPLC products, integrated solutions, and software. These offerings cater to biopharma/pharma research, clinical diagnostics, environmental testing, food and beverage analysis, cannabis and hemp testing, forensic testing, and biomedical and omics research. The company offers instrument control software, accessories, standards, and reagent kits. The company's solutions support drug discovery, impurity analysis, protein therapeutics, water analysis, food safety, pesticide testing, and forensic toxicology. The company provides online support, technical documents, training, and professional services. The company's technologies include high-resolution accurate mass spectrometry, acoustic ejection mass spectrometry, and ultra-low-flow CESI technology. The company offers cloud based software, login, subscription, and support services.

Website: intabio.com
Social
Email ID: *****@intabio.com
Phone Number: +1 **********

Key Metrics

Founded Year

2015

Location

Sunnyvale, United States

Stage

Acqui-Hired

Total Funding

$30.7M in 4 rounds

Latest Funding Round

Series B, Feb 06, 2020, $*****

Investors

Northpond Ventures & 10 more

Ranked

10^th among 67 active competitors

Employee Count

16 as on Jul 01, 2024

Similar Companies

Biological Dynamics & 84 more

View Intabio's full profile

Intabio has raised a total funding of $30.7M over 4 rounds. Its first funding round was on Sep 14, 2017. Its latest funding round was a Series B round on Feb 06, 2020 for $*****. 3 investors participated in its latest round. Intabio has 10 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Intabio:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 06, 2020	7196545	Series B	2698588	1812828	1929590	8177096
Oct 30, 2018	3685115	Series A	5213677	6207164	7374615	Vertical Venture Partners & 1 more
Jan 01, 2018	8922405	Grant (prize money)	4618923	4785123	3881589	National Science Foundation

Access funding benchmarks and valuations. Sign up today!

View details of Intabio's funding rounds and investors

The founders of Intabio is Lena Wu. Lena Wu is the CEO of Intabio.

Here are the details of Intabio's key team members:

Lena Wu: Co-Founder, CEO & President of Intabio.

View details of Intabio's Founder profiles and Board Members

Intabio's employee count trend

Intabio has 16 employees as of Jul 24. Here is Intabio's employee count trend over the years:

Uncover Intabio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Intabio include Biological Dynamics, Fluidic Analytics and Miroculus. Here is the list of Top 10 competitors of Intabio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Biological Dynamics 2010, San Diego (United States), Series C	Provider of molecular diagnostics plaform	$67.6M	Alexandria, Heritage Group & 6 others	57/100
2nd	Fluidic Analytics 2013, Cambridge (United Kingdom), Series C	Develops microfluidic-based tools for protein characterization	$40.5M	Draper Esprit, IQ Capital & 23 others	54/100
3rd	Miroculus 2014, San Francisco (United States), Acquired	Developer of MicroRNA profiling platform to detect genes in the sample	$48.4M	Cota Capital, Nazca & 11 others	50/100
4th	Precision Nanosystems 2010, Vancouver (Canada), Acquired	Manufactures instruments, kits, and reagents for nanomedicine development	$25.4M	5AM Ventures, Telegraph Hill Partners & 8 others	44/100
5th	IDEX Health & Science 2002, Rohnert Park (United States), Unfunded	Optofluidic and optical solutions for life science and health industries	-	-	44/100
6th	Cellix 2006, Dublin (Ireland), Acquired	Manufacturer of microfluidics, biochips, high-throughput cell membrane and gene editing technology	$1.05M	OTC Agregator, Investec & 3 others	42/100
7th	Microcaps 2018, Zurich (Switzerland), Series A	Developer of microﬂuidic-based technology	$16.2M	Zurcher Kantonalbank, Helvetica Capital & 6 others	42/100
8th	Advanced Liquid Logic 2004, Durham (United States), Acquired	Bioassay protocols using digital microfluidics	$5M	Square 1 Bank, NCBiotech & 2 others	41/100
9th	PharmaSeq 1999, Monmouth Junction (United States), Series A	Developer and markets p-Chip Micro transponders	$3M	NHGRI, National Cancer Institute & 3 others	40/100
10th	Intabio 2015, Sunnyvale (United States), Acqui-Hired	Analytical solutions for life science, diagnostics, and applied markets	$30.7M	Windward Capital Ventures, Northpond Ventures ... & 9 others	40/100